Outcome of children with community acquired pneumonia treated with injection crystalline penicillin a prospective study
Abstract
Objective: To study the outcome of children hospitalized with community acquired pneumonia treated with aqueous penicillin G.
Design: Prospective study. S
etting: The study was conducted in Belagavi Institute of Medical Sciences, a referral hospital during 2014-2015. Children aged from more than 2 months to 18yrs of age were studied. Total of 84 children who met the inclusion criteria were studied. Eligible children were given injection crystalline penicillin 2 lakh IU/kg in four divided doses after drug sensitivity testing. Children were assessed every 12th hourly, for respiratory rate, pulse rate, blood pressure and signs of respiratory distress. In case of worsening of symptoms, persistence of tachynpea, fever, till 48 hours, antibiotic was changed. The study was conducted to know the proportion of children with community acquired pneumonia who responded to crystalline penicillin injection.
Results: Out of 84 children treated with crystalline penicillin 79 responded, antibiotic was changed for the other 5 children. 3 boys out of 48 and 2 girls out of 36 did not respond to crystalline penicillin. 2 out of 24 children in the age group of 2-12 months, 3 out of 33 in the 1-5 yrs, did not respond to crystalline penicillin. Persistence of tachypnea at the end of 48 hours was the indication for change of change of antibiotics in 5 children. No adverse outcome was noted. The mean duration of stay in the hospital among the studied children was 7days (6.93±1.28).
Conclusion: Injection crystalline penicillin effectively cures and is apt to be used as a first line antibiotic in treating hospitalized children with community acquired pneumonia.
Downloads
References
2. Goossens H, Sprenger MJ. Community acquired infections and bacterial resistance. BMJ. 1998 Sep 5;317(7159):654-7. [PubMed]
3. Mehta PN. Choosing antibiotics for community acquired pneumonia. Indian Pediatr. 2003 Oct;40(10):958-64. [PubMed]
4. Jadavji T, Law B, Lebel MH, Kennedy WA, Gold R, Wang EE. A practical guide for the diagnosis and treatment of pediatric pneumonia. CMAJ. 1997 Mar 1;156(5):S703-11. [PubMed]
5. British Thoracic Society Standards of Care Committee. British Thoracic Society Guidelines for the Management of Community Acquired Pneumonia in Childhood. Thorax. 2002 May;57 Suppl 1:i1-24. [PubMed]
6. Esposito S, Principi N. Unsolved problems in the approach to pediatric community-acquired pneumonia. Curr Opin Infect Dis. 2012 Jun;25(3):286-91. doi: 10.1097/QCO.0b013e328352b60c. [PubMed]
7. WORLD Health Organization. Pneumonia: The forgotten killer of children. The United Nations Children’s Fund /World Health Organization; Sept 2006.
8. Bharti B, Bharti S, Verma V. Role of Acute Illness Observation Scale (AIOS) in managing severe childhood pneumonia. Indian J Pediatr. 2007 Jan;74(1):27-32.
9. Gershel JC, Goldman HS, Stein RE, Shelov SP, Ziprkowski M. The usefulness of chest radiographs in first asthma attacks. N Engl J Med. 1983 Aug 11;309(6):336-9. [PubMed]
10. Raquel Simbalista,MarceloArau´ jo,Cristiana M. Nascimento-Carvalho. Outcome of children hospitalized with community-acquired pneumonia treated with aqueous penicillin G. CLINICS 2011; 66(1):95-100. [PubMed]
11. Jadavji T, Law B, Lebel MH, Kennedy WA, Gold R, Wang EE. A practical guide for the diagnosis and treatment of pediatric pneumonia. CMAJ. 1997 Mar 1;156(5):S703-11. [PubMed]
12. British Thoracic Society of Standards of Care Committee. BTS guideline for the management of community acquired pneumonia in children.Thorax. 2002; 57:i1-24.
13. Juvén T, Mertsola J, Waris M, Leinonen M, Ruuskanen O. Clinical response to antibiotic therapy for community-acquired pneumonia. Eur J Pediatr. 2004 Mar;163(3):140-4. Epub 2004 Jan 31. [PubMed]
14. Hedlund J, Ortqvist A, Ahlqvist T, Augustinsson A, Beckman H, Blanck C, Burman LA, Claesson B, Qvarfordt I, Elbel E, Erntell M, Follin P, Goscinski G, Holmberg H, Höfer M, Jorup C, Lidman C, Lindhusen E, Rensfeldt G, Rosenkvist E, Stenlund G, Stålberg A, Verngren K, Vig I, Wendahl S; Swedish Infectious Diseases Society Pneumonia Study Group. Management of patients with community-acquired pneumonia treated in hospital in Sweden. Scand J Infect Dis. 2002;34(12):887-92. [PubMed]
15. Moroney JF, Fiore AE, Harrison LH, Patterson JE, Farley MM, Jorgensen JH et al. Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance. Clin Infect Dis 2001;33:797–805. [PubMed]
16. Ruuskanen O, Mertsola J. Childhood community-acquired pneumonia. Semin Respir Infect. 1999 Jun;14(2):163-72. [PubMed]
17. Nelson JD. Community-acquired pneumonia in children: guidelines for treatment. Pediatr Infect Dis J. 2000 Mar;19(3):251-3. [PubMed]
18. Pihlajamäki M, Kotilainen P, Kaurila T, Klaukka T, Palva E, Huovinen P; Finnish Study Group for Antimicrobial Resistance (FiRe-Network). Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents. Clin Infect Dis. 2001 Aug 15;33(4):483-8. Epub 2001 Jul 20. [PubMed]
Copyright (c) 2016 Author (s). Published by Siddharth Health Research and Social Welfare Society
This work is licensed under a Creative Commons Attribution 4.0 International License.
OAI - Open Archives Initiative
